Skip to content
Search

Latest Stories

40% of Brits ready to embrace pharmacy delivery service

40% of Brits ready to embrace pharmacy delivery service

Same-day delivery and real-time tracking could be key to winning over consumers skeptical about pharmacy delivery service

A survey report by market research and data analytics firm, YouGov, has indicated that while there is a demand for home pharmacy delivery among consumers, the current supply or awareness of this type of service appears to be low.


The poll found that approximately one-fifth of British consumers (18 per cent) have used a pharmacy delivery service in the past year.

However, more than double that figure (40 per cent) expressed their intent to use such a service in the next 12 months if it were available, suggesting an opportunity for growth in this sector.

This difference is especially pronounced in the Midlands, Scotland, and Wales, where the potential demand more than triples actual use.

Compared to other regions, the current use of pharmacy delivery services is notably low in the Midlands, standing at 12 per cent, and in Wales and Scotland, where the collective usage rate stands at 14 per cent.

Consumer demand for pharmacy delivery services far exceeds current usage levels in all regions, except for the East, where only 28 per cent of consumers expressed willingness to have their medications delivered.

Convenience and transportation issues were cited as the primary reasons for preferring a delivery service over in-store pick-up.

Among consumers open to using a pharmacy delivery service, 79 per cent cited convenience as a reason, followed by transportation-related concerns, such as being too ill to get to the physical shop (33 per cent) and the need for urgent delivery (16 per cent).

While older consumers are concerned with difficulties getting to the pharmacy, younger consumers want contactless medication delivery.

However, a notable proportion of British consumers (39 per cent) said that they would not use a pharmacy delivery service even if it were accessible. To make the service more appealing to these skeptical consumers, same-day delivery emerged as the top choice, selected by 42 per cent of respondents.

Moreover, skeptical consumers, especially younger ones, want real-time tracking to improve delivery services.

Drugstore chain Superdrug has recently collaborated with the delivery service Gophr to introduce home pharmacy delivery across the UK. While they are not the first to offer this service, this new partnership is seen as the entry of a new major player into the market.

YouGov report suggested that there’s plenty of room for growth in this market, especially if brands cater to the preferences of those skeptical about delivery services.

 

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less